With over 37 years of design and manufacturing experience, Michael Bourque is a Boston-based inventor driven by a passion for turning bold ideas into reality. We crossed paths online and have never actually met, even though we worked for the same company for a short period of time.Unable to afford college, he embarked on a journey through trade school, emerging as a skilled machinist. Diligence propelled him to swiftly ascend the ranks, ultimately achieving a prominent programming position at MIT's Lincoln Laboratory.Shifting into software leadership, he became a Vice President at PTC, a distinguished $1.3 billion high-tech software enterprise based in Boston. Along the way he also founded a product company, raised $7.5 million, and negotiated a profitable exit.I consider Michael to truly be a renaissance man. He excels at everything he touches, and has a wide variety of interests. When not working, he channels his creativity into painting, music composition, filmmaking, and artistry. In my interview, we will touch on his many pursuits, but focus primarily on his songwriting skills. Although his musicianship is largely unknown to the world, it is my hope that this hour interview will give viewers an appreciation for his artistry.
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
Before the Crisis: How You and Your Relatives Can Prepare for Financial Caregiving
06 Dec 2025
Motley Fool Money
OpenAI's Code Red, Sacks vs New York Times, New Poverty Line?
06 Dec 2025
All-In with Chamath, Jason, Sacks & Friedberg
OpenAI's Code Red, Sacks vs New York Times, New Poverty Line?
06 Dec 2025
All-In with Chamath, Jason, Sacks & Friedberg
Anthropic Finds AI Answers with Interviewer
05 Dec 2025
The Daily AI Show
#2423 - John Cena
05 Dec 2025
The Joe Rogan Experience
Warehouse to wellness: Bob Mauch on modern pharmaceutical distribution
05 Dec 2025
McKinsey on Healthcare